Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Diabetic nephropathy: evidence for renoprotection and practice
by
Mogensen, Carl-Erik
in
ACE inhibitors
/ Adrenergic beta-Antagonists - therapeutic use
/ Albuminuria - drug therapy
/ Angiotensin Receptor Antagonists
/ Angiotensin-Converting Enzyme Inhibitors - therapeutic use
/ Benzimidazoles - therapeutic use
/ Blood pressure
/ Calcium Channel Blockers - therapeutic use
/ Cardiovascular Diseases - prevention & control
/ Diabetes
/ Diabetic Nephropathies - drug therapy
/ Diuretics - therapeutic use
/ Enzymes
/ Glomerular Filtration Rate - drug effects
/ Glomerulonephritis, Membranous - prevention & control
/ Humans
/ Kidney diseases
/ Metabolism
/ Mortality
/ Randomized Controlled Trials as Topic
/ Receptor, Angiotensin, Type 1
/ Receptor, Angiotensin, Type 2
/ Studies
/ Tetrazoles - therapeutic use
2000
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Diabetic nephropathy: evidence for renoprotection and practice
by
Mogensen, Carl-Erik
in
ACE inhibitors
/ Adrenergic beta-Antagonists - therapeutic use
/ Albuminuria - drug therapy
/ Angiotensin Receptor Antagonists
/ Angiotensin-Converting Enzyme Inhibitors - therapeutic use
/ Benzimidazoles - therapeutic use
/ Blood pressure
/ Calcium Channel Blockers - therapeutic use
/ Cardiovascular Diseases - prevention & control
/ Diabetes
/ Diabetic Nephropathies - drug therapy
/ Diuretics - therapeutic use
/ Enzymes
/ Glomerular Filtration Rate - drug effects
/ Glomerulonephritis, Membranous - prevention & control
/ Humans
/ Kidney diseases
/ Metabolism
/ Mortality
/ Randomized Controlled Trials as Topic
/ Receptor, Angiotensin, Type 1
/ Receptor, Angiotensin, Type 2
/ Studies
/ Tetrazoles - therapeutic use
2000
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Diabetic nephropathy: evidence for renoprotection and practice
by
Mogensen, Carl-Erik
in
ACE inhibitors
/ Adrenergic beta-Antagonists - therapeutic use
/ Albuminuria - drug therapy
/ Angiotensin Receptor Antagonists
/ Angiotensin-Converting Enzyme Inhibitors - therapeutic use
/ Benzimidazoles - therapeutic use
/ Blood pressure
/ Calcium Channel Blockers - therapeutic use
/ Cardiovascular Diseases - prevention & control
/ Diabetes
/ Diabetic Nephropathies - drug therapy
/ Diuretics - therapeutic use
/ Enzymes
/ Glomerular Filtration Rate - drug effects
/ Glomerulonephritis, Membranous - prevention & control
/ Humans
/ Kidney diseases
/ Metabolism
/ Mortality
/ Randomized Controlled Trials as Topic
/ Receptor, Angiotensin, Type 1
/ Receptor, Angiotensin, Type 2
/ Studies
/ Tetrazoles - therapeutic use
2000
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Diabetic nephropathy: evidence for renoprotection and practice
Journal Article
Diabetic nephropathy: evidence for renoprotection and practice
2000
Request Book From Autostore
and Choose the Collection Method
Overview
[...]the study has not been running for a sufficient length of time to show an effect on proteinuria. [...]as the development of overt nephropathy takes decades, useful data will not be available for some time. [...]it appears that effective treatment with ACE inhibitors can prevent or postpone advanced nephropathy in patients with type 1 and 2 diabetes and postpone end stage renal disease.
Publisher
BMJ Publishing Group Ltd and British Cardiovascular Society,BMJ Publishing Group LTD
Subject
/ Adrenergic beta-Antagonists - therapeutic use
/ Angiotensin Receptor Antagonists
/ Angiotensin-Converting Enzyme Inhibitors - therapeutic use
/ Benzimidazoles - therapeutic use
/ Calcium Channel Blockers - therapeutic use
/ Cardiovascular Diseases - prevention & control
/ Diabetes
/ Diabetic Nephropathies - drug therapy
/ Enzymes
/ Glomerular Filtration Rate - drug effects
/ Glomerulonephritis, Membranous - prevention & control
/ Humans
/ Randomized Controlled Trials as Topic
/ Receptor, Angiotensin, Type 1
/ Receptor, Angiotensin, Type 2
/ Studies
This website uses cookies to ensure you get the best experience on our website.